Search Login Register

rivaroxaban Summary

Description: antithrombotic agent inhibits Factor Xa; structure in first source

Also Known As: 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide; BAY 59-7939

Networked: 1029 relevant articles (110 outcomes, 339 trials/studies) for this Bio-Agent

Key Diseases for which rivaroxaban is Relevant

  1. Hemorrhage : 29 outcomes 90 studies in 340 results
  2. Stroke (Strokes) : 24 outcomes 127 studies in 339 results
  3. Venous Thromboembolism : 22 outcomes 72 studies in 247 results
  4. Atrial Fibrillation : 21 outcomes 110 studies in 347 results
  5. Pulmonary Embolism : 11 outcomes 22 studies in 96 results
Show All >>

Drugs Related to rivaroxaban

  1. Warfarin (Coumadin)
  2. apixaban
  3. Enoxaparin (Lovenox)
  4. Factor Xa (Coagulation Factor Xa)
  5. Anticoagulants
  6. Vitamin K
  7. edoxaban
  8. Thrombin
  9. Aspirin (Acetylsalicylic Acid)
  10. N(4)-oleylcytosine arabinoside
Show All >>

Therapies Related to rivaroxaban

  1. Arthroplasty
  2. Knee Replacement Arthroplasty (Total Knee Replacement)
  3. Hip Replacement Arthroplasty (Total Hip Replacement)
  4. Electric Countershock (Cardioversion)
  5. Oral Administration
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.